Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 16, 2026
HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 01, 2026
CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma.
Journal: Future oncology (London, England)
Published: January 11, 2025
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 12, 2016
Showing 1-5 of 5
Last Updated: 09/26/2026